New effective drug for Cushing's syndrome

The steroidogenesis inhibitor levoketoconazole has improved laboratory parameters in adult patients with endogenous Cushing's disease.

The World Health Organization expects to receive at least 2 billion doses of COVID-19 vaccines next year

The World Health Organization expects to receive 2 billion doses of COVID-19 vaccines under the COVAX program in 2021.

GALAPAGOS and GILEAD have demonstrated victory over scleroderma

Experts believe that GALAPAGOS and GILEAD have managed to make a breakthrough on an experimental autotoxin inhibitor in the field of scleroderma therapy.

VIR Biotechnology has demonstrated a new effective drug for hepatitis B prevention

Clinical studies on VIR-2218 have shown an effective result in the fight against hepatitis B.

Orphan drug status has been assigned to new glioblastoma drug

The FDA has assigned an orphan drug status to a drug based on rhenium nanoliposom.

Tumor hypoxia - a new method for fighting cancer

A new class of drugs such as HIF-2α inhibitors is considered as an addition to standard cancer immunotherapy.

Development of a new generation of immunomodulators

Chinese scientists are actively engaged in the development of improved immunomodulators.

Scientists have revealed plastic particles in human bodies

Studies have shown that, on average, people eat about 5 grams of plastic every week.

New genome editing technology

A new control dyslipidemia method has been proposed instead of appropriate statins and lipid-lowering drugs.

Scientists have developed a new rabies vaccine

Chinese scientists have developed a unique vaccine that is safe and has low adverse reactions.